Email not displaying correctly? View it in your browser.
Mayo Clinic PsychUpdate e-Edition
December 2014
Follow us:   Facebook icon Twitter icon Youtube icon  
anchor arrowResearch | anchor arrowEducation | anchor arrowIn the Video Center |anchor arrowConsults & Referrals | anchor arrowResources
Advancing the Science - Pharmacogenomics
Patient Care

Pharmacogenomics task force identifies genetic variants with implications for drug therapy

In a key innovation developed by a Mayo task force, if a patient is at risk of a drug-gene interaction, a warning appears when the clinician enters the prescribed medication into the patient's EMR.


Pharmacogenomic testing may improve treatment for patients with depression
A new Mayo Clinic study explores whether pharmacogenomic testing should be part of regular clinical practice — before antidepressant therapy starts — to minimize the number of unsuccessful medication trials for patients with depressive disorder.

Study explores SSRI action at the molecular level in patients with MDD
Mayo researchers have performed the first genome-wide association study for plasma concentrations of escitalopram and its metabolites in patients with major depressive disorder who were treated with the medication.

See all Psychiatry and Psychology Clinical Trials at Mayo Clinic

Back To Top

Psychiatry in Medical Settings
Jan. 22-24, 2015, in New Orleans
Mayo Clinic faculty will review principles of psychiatric diagnosis and treatment of patients in medical and surgical inpatient and outpatient settings.

Aeschi 8: Bearing the Struggle: Exploring the Challenges Facing Clinicians Working with Suicidal Patients
June 11-13, 2015, in Vail, Colorado
This videotape-based workshop in suicide assessment and treatment helps attendees understand the experiences of the suicidal patient and the responses of the therapist to that patient's narrative. In each scenario, patient and therapist will co-construct an appropriate treatment plan.

See all Psychology & Psychiatry Continuous Professional Development Courses

Back To Top
In the Video Center

Somatic Symptoms Disorders, Part I: New Terminology for New Concepts
Jeffrey P. Staab, M.D., discusses the concepts that led to the development of the new terminology for the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5).

Part II: Core Features and Treatment

Part III: Fallacy of Medically Unexplained Thinking

View videos by specialty and Grand Rounds presentations online

Back To Top
Consults & Referrals

Back To Top

Back To Top

Comments Comments?
We're interested in your feedback about this newsletter
Mayo Clinic

13400 East Shea Blvd.
Scottsdale, AZ 85259

4500 San Pablo Road
Jacksonville, FL 32224

200 First St. SW
Rochester, MN 55905

Share Pass It On!
Invite a friend to subscribe by forwarding this newsletter

Mayo Clinic shield logo | Newsletter Archive | Contact | Medical Professionals

© 2014 Mayo Foundation for Medical Education and Research
200 First Street SW, Rochester, MN 55905. All rights reserved.
Terms of Use